{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:19:40Z","timestamp":1787685580771,"version":"build-2784847793"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41375-026-03025-x","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:36:30Z","timestamp":1783326990000},"page":"2039-2042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retroperitoneal bulk predicts chylothorax in follicular lymphoma\u2013control requires systemic response"],"prefix":"10.1038","volume":"40","author":[{"given":"Denis","family":"Terziev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska Lea","family":"Sch\u00fcmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Behlendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Eisenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-9559","authenticated-orcid":false,"given":"Elisabeth","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-9044","authenticated-orcid":false,"given":"Michael","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-9348","authenticated-orcid":false,"given":"Thomas","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"3025_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2009.08.010","volume":"104","author":"EE McGrath","year":"2010","unstructured":"McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med. 2010;104:1\u20138.","journal-title":"Respir Med"},{"key":"3025_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1378\/chest.14-2199","volume":"148","author":"AC Bibby","year":"2015","unstructured":"Bibby AC, Clive AO, Slade GC, Morley AJ, Fallon J, Psallidas I, et al. Survival in patients with malignant pleural effusions who developed pleural infection: a retrospective case review from six UK centers. Chest. 2015;148:235\u201341.","journal-title":"Chest"},{"key":"3025_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/01.mcp.0000230629.73139.26","volume":"12","author":"I Kalomenidis","year":"2006","unstructured":"Kalomenidis I. Octreotide and chylothorax. Curr Opin Pulm Med. 2006;12:264\u20137.","journal-title":"Curr Opin Pulm Med"},{"key":"3025_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/oxfordjournals.annonc.a059251","volume":"6","author":"AM O\u2019Callaghan","year":"1995","unstructured":"O\u2019Callaghan AM, Mead GM. Chylothorax in lymphoma: mechanisms and management. Ann Oncol. 1995;6:603\u20137.","journal-title":"Ann Oncol"},{"key":"3025_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1378\/chest.114.3.731","volume":"114","author":"DC Mares","year":"1998","unstructured":"Mares DC, Mathur PN. Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: a case series. Chest. 1998;114:731\u20135.","journal-title":"Chest"},{"key":"3025_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0991-3","volume":"14","author":"J Pospiskova","year":"2019","unstructured":"Pospiskova J, Smolej L, Belada D, Simkovic M, Motyckova M, Sykorova A, et al. Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders. Orphanet J Rare Dis. 2019;14:9.","journal-title":"Orphanet J Rare Dis"},{"key":"3025_CR7","doi-asserted-by":"publisher","first-page":"684689","DOI":"10.1155\/2014\/684689","volume":"2014","author":"L Van De Voorde","year":"2014","unstructured":"Van De Voorde L, Vanneste B, Borger J, Troost EG, Werner P. Rapid decline of follicular lymphoma-associated chylothorax after low-dose radiotherapy to retroperitoneal lymphoma localization. Case Rep Hematol. 2014;2014:684689.","journal-title":"Case Rep Hematol"},{"key":"3025_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11864-006-0036-3","volume":"7","author":"P Solal-Celigny","year":"2006","unstructured":"Solal-Celigny P. Follicular lymphoma international prognostic index. Curr Treat Options Oncol. 2006;7:270\u20135.","journal-title":"Curr Treat Options Oncol"},{"key":"3025_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","volume":"5","author":"A Carbone","year":"2019","unstructured":"Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, Lopez-Guillermo A, et al. Follicular lymphoma. Nat Rev Dis Primers. 2019;5:83.","journal-title":"Nat Rev Dis Primers"},{"key":"3025_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","volume":"156","author":"BE Wahlin","year":"2012","unstructured":"Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, et al. Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times. Br J Haematol. 2012;156:225\u201333.","journal-title":"Br J Haematol"},{"key":"3025_CR11","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3324\/haematol.2022.281375","volume":"108","author":"A Barraclough","year":"2023","unstructured":"Barraclough A, England JT, Villa D, Wight J, Hapgood G, Conn J, et al. Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance. Haematologica. 2023;108:2444\u201353.","journal-title":"Haematologica"},{"key":"3025_CR12","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1200\/JCO.2017.76.8960","volume":"36","author":"W Hiddemann","year":"2018","unstructured":"Hiddemann W, Barbui AM, Canales MA, Cannell PK, Collins GP, Durig J, et al. Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study: influence of chemotherapy on efficacy and safety. J Clin Oncol. 2018;36:2395\u2013404.","journal-title":"J Clin Oncol"},{"key":"3025_CR13","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1182\/blood-2006-03-013193","volume":"108","author":"C Sebban","year":"2006","unstructured":"Sebban C, Mounier N, Brousse N, Belanger C, Brice P, Haioun C, et al. Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA). Blood. 2006;108:2540\u20134.","journal-title":"Blood"},{"key":"3025_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1183\/09031936.97.10051157","volume":"10","author":"G Hillerdal","year":"1997","unstructured":"Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J. 1997;10:1157\u201362.","journal-title":"Eur Respir J"},{"key":"3025_CR15","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1007\/s00270-021-02931-0","volume":"44","author":"F Streitparth","year":"2021","unstructured":"Streitparth F, Theurich S, Streitparth T, Ocal O, Dos Santos DC, Flatz W. Treatment of refractory high-flow chylothorax in high-grade B-cell lymphoma by intratumoral lymphatic embolization. Cardiovasc Interv Radiol. 2021;44:2002\u20134.","journal-title":"Cardiovasc Interv Radiol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03025-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:02:22Z","timestamp":1787684542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03025-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3025"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03025-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and local data protection regulations (\u00a715 of the professional regulations of the Medical Association of Saxony-Anhalt, Germany). Ethical approval was obtained from the Ethics Committee of the Martin-Luther-University Halle-Wittenberg.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent to participate in the study and for publication of individual clinical data was obtained from all patients.","order":3,"name":"Ethics","label":"Patient consent statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}